Jane E. Visvader
Oncology · 2006–2023
A researcher in the Science corpus: 11 papers; trusts 28 researchers and is trusted by 14 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 176 citations into it; #164 of 1,698 by trust here, #200 by citations
- Molecular Biology — 146 citations into it; #5,374 of 17,773 by trust here, #3,562 by citations
- Cancer Research — 104 citations into it
- Genetics — 90 citations into it
- Immunology — 36 citations into it
- Pathology and Forensic Medicine — 33 citations into it
- Hematology — 23 citations into it
- Cell Biology — 18 citations into it; #762 of 2,073 by trust here, #894 by citations
Whom Jane E. Visvader trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Dontu
- Mark Shackleton
- Eric C. Holland
- T. Reya
- Catriona H. M. Jamieson
- M. Clarke
- J. Dick
- Hans Clevers
- E. Quintana
- Nick Barker
Who trusts Jane E. Visvader overall
- V. Plaks
- Christine L. Chaffer
- Christophe Klein
- Niwen Kong
- J. Rock
- M. Shen
- X. Ye
- S. Nik-Zainal
- J. Medema
- Geou-Yarh Liou
Papers from Jane E. Visvader's perspective
Ordered by how strongly the researchers Jane E. Visvader trusts endorse each paper. Same corpus, a different order for every researcher.
- Prospective identification of tumorigenic breast cancer cells (Proceedings of the National Academy of Sciences of the United States of America)
- Efficient tumor formation by single human melanoma cells (Nature)
- In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. (Genes & Development)
- Identification of human brain tumour initiating cells (Nature)
- Stem cells, cancer, and cancer stem cells (Nature)
- Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. (Journal of the National Cancer Institute)
- A human colon cancer cell capable of initiating tumour growth in immunodeficient mice (Nature)
- Molecular portraits of human breast tumours (Nature)
- ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. (Cell Stem Cell)
- Identification of a cancer stem cell in human brain tumors. (Cancer Research)
Their papers
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers (2009) — 1,475 citations
- Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation (2007) — 840 citations
- Cancer stem cells in solid tumours: accumulating evidence and unresolved questions (2008) — 3,532 citations
- Cancer stem cells: current status and evolving complexities. (2012) — 1,280 citations
- Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. (2009) — 623 citations
- Genome-wide association study identifies novel breast cancer susceptibility loci (2007) — 2,354 citations
- Deciphering breast cancer: from biology to the clinic. (2023) — 632 citations
- Cells of origin in cancer (2011) — 1,493 citations
- Control of mammary stem cell function by steroid hormone signalling (2010) — 705 citations
- Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. (2006) — 3,082 citations
- Generation of a functional mammary gland from a single stem cell (2006) — 2,120 citations